Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial-Reference-Cited by-同舟云学术

Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial

Published:2019-03 Issue:10175 Volume:393 Page:987-997
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Zaman Azfar,de Winter Robbert J,Kogame Norihiro,Chang Chun Chin,Modolo Rodrigo,Spitzer Ernest,Tonino Pim,Hofma Sjoerd,Zurakowski Aleksander,Smits Pieter C,Prokopczuk Janusz,Moreno Raul,Choudhury Anirban,Petrov Ivo,Cequier Angel,Kukreja Neville,Hoye Angela,Iniguez Andrés,Ungi Imre,Serra Antonio,Gil Robert J,Walsh Simon,Tonev Gincho,Mathur Anthony,Merkely Bela,Colombo Antonio,Ijsselmuiden Sander,Soliman Osama,Kaul Upendra,Onuma Yoshinobu,Serruys Patrick W

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Endothelial cell recovery between comparator polymer-based drug-eluting stents;Joner;J Am Coll Cardiol,2008

2. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project;Nebeker;J Am Coll Cardiol,2006

3. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis;Palmerini;J Am Coll Cardiol,2015

4. 2018 ESC/EACTS guidelines on myocardial revascularization;Neumann;Eur Heart J,2018

5. A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial;de Winter;Lancet,2018

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial;The Lancet;2024-09

2. Clinical outcomes with biodegradable versus durable polymer drug-eluting stents in patients with ST-elevation myocardial infarction;Cardiovascular Revascularization Medicine;2024-08

3. Comparative effectiveness of ultrathin vs. standard strut drug-eluting stents: insights from a large-scale meta-analysis with extended follow-up;European Journal of Medical Research;2024-07-27

4. Safety and efficacy of the latest generation biodegradable polymer-coated ultrathin sirolimus-eluting stent in the treatment of coronary artery disease in a European all-comer population with or without high bleeding risk: The Cruz HBR Registry;Minerva Cardiology and Angiology;2024-06

5. One-Year Outcomes of Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stent in Acute Coronary Syndrome: A Patient-Level Pooled Analysis from Two Indian Registries;Cardiology;2024-05-07